Paradigm Biocapital Advisors LP

OLMA

Paradigm Biocapital Advisors LP serves as 10% Owner at Olema Pharmaceuticals, Inc. (OLMA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$1.16M

Total Sells

1 trades

$35.80M

Net Position

Net Seller

$34.64M

Companies Traded

OLMA

Active Period

Dec 2023 – Aug 2024

2 total trades

Most Recent

Sell OLMA

Aug 5, 2024 · $35.80M

Paradigm Biocapital Advisors LP's Insider Trading at Olema Pharmaceuticals, Inc. (OLMA)

Buys

1 · $1.16M

Sells

1 · $35.80M

Total Shares Bought

100,000

Total Shares Sold

2,400,000

OLMA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 5, 2024	Sell	2,400,000	$14.92	$35.80M	4,720,482
Dec 8, 2023	Buy	100,000	$11.60	$1.16M	6,590,981

Related Insiders

Shawnte Mitchell

officer: CHIEF LEGAL OFFICER

OLMASell · Mar 5, 2026

Cyrus Harmon

director

OLMASell · Jan 21, 2026

Shane William Charles Kovacs

officer: CH. OPERATING & FINANCIAL OFF.

OLMASell · Jan 15, 2026

David C. Myles

officer: CH. DISCOV. & NON-CLIN DEV OFF

OLMASell · Jan 14, 2026

CLARK IAN T

OLMASell · Dec 23, 2025

Naseem Zojwalla

Chief Medical Officer

OLMASell · Dec 23, 2025

Explore More Insider Trading Data

OLMA Insider Trading Activity

View all insider trades at Olema Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity